Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose intravenous ketamine versus placebo for prevention of post-spinal anesthesia headache after cesarean section
IRCT20120215009014N387Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in post-dural puncture headache (PDPH) and Headache comparing Ketamine with Placebo (2 arms). Primary endpoint: Headache. Started Apr 2021; status: completed.
02
Drugs
ketamine
03
Conditions
post-dural puncture headache (PDPH)Headache
Beyond the preview
Go deeper on IRCT20120215009014N387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N387.